Quantbot Technologies’s Trillium Therapeutics Inc. TRIL Stock Holding History

Quantbot Technologies’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,900	Closed	-$121K	–	2080
2021 Q3	$121K	Buy	+6,900	New	+$80.6K	0.01%	918

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Quantbot Technologies's TRIL Position: Q4 2021 in Review

Quantbot Technologies sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 6,900 shares — an estimated $121K sold.

Quantbot Technologies first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $121K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Quantbot Technologies reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Quantbot Technologies sold 6,900 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $121K.
Quantbot Technologies first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Quantbot Technologies's Trillium Therapeutics Inc. position peaked at $121K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Quantbot Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.